000201862 001__ 201862
000201862 005__ 20210129215933.0
000201862 0247_ $$2doi$$a10.1136/jnnp-2012-303524.95
000201862 0247_ $$2ISSN$$a0022-3050
000201862 0247_ $$2ISSN$$a0266-8637
000201862 0247_ $$2ISSN$$a0368-329X
000201862 0247_ $$2ISSN$$a1468-330X
000201862 0247_ $$2WOS$$aWOS:000320868800096
000201862 037__ $$aFZJ-2015-04156
000201862 082__ $$a610
000201862 1001_ $$0P:(DE-Juel1)138474$$aMatusch, A.$$b0$$eCorresponding Author$$ufzj
000201862 1112_ $$aPlenary Meeting of the European-Huntington's-Disease-Network (EHDN)$$cStockholm$$d2012-09-14 - 2012-09-16$$wSweden
000201862 245__ $$aG15 Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease: a PET study
000201862 260__ $$aLondon$$bBMJ Publishing Group$$c2012
000201862 300__ $$aA31
000201862 3367_ $$0PUB:(DE-HGF)8$$2PUB:(DE-HGF)$$aContribution to a conference proceedings$$bcontrib$$mcontrib$$s1435297953_10112
000201862 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000201862 3367_ $$033$$2EndNote$$aConference Paper
000201862 3367_ $$2ORCID$$aCONFERENCE_PAPER
000201862 3367_ $$2DataCite$$aOutput Types/Conference Paper
000201862 3367_ $$2DRIVER$$aconferenceObject
000201862 3367_ $$2BibTeX$$aINPROCEEDINGS
000201862 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000201862 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000201862 7001_ $$0P:(DE-HGF)0$$aSaft, C.$$b1
000201862 7001_ $$0P:(DE-Juel1)131679$$aElmenhorst, D.$$b2$$ufzj
000201862 7001_ $$0P:(DE-HGF)0$$aKraus, P.$$b3
000201862 7001_ $$0P:(DE-HGF)0$$aGold, R.$$b4
000201862 7001_ $$0P:(DE-HGF)0$$aHartung, H.-P.$$b5
000201862 7001_ $$0P:(DE-Juel1)131672$$aBauer, Andreas$$b6$$ufzj
000201862 773__ $$0PERI:(DE-600)1480429-3$$a10.1136/jnnp-2012-303524.95$$gVol. 83, no. Suppl 1, p. A31 - A31$$nSuppl 1$$tJournal of neurology, neurosurgery, and psychiatry$$v83$$x0022-3050$$y2012
000201862 909CO $$ooai:juser.fz-juelich.de:201862$$pVDB
000201862 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)138474$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000201862 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131679$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000201862 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131672$$aForschungszentrum Jülich GmbH$$b6$$kFZJ
000201862 9132_ $$0G:(DE-HGF)POF3-571$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vConnectivity and Activity$$x0
000201862 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000201862 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000201862 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000201862 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000201862 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000201862 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000201862 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000201862 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000201862 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000201862 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000201862 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000201862 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000201862 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5
000201862 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000201862 980__ $$acontrib
000201862 980__ $$aVDB
000201862 980__ $$ajournal
000201862 980__ $$aI:(DE-Juel1)INM-2-20090406
000201862 980__ $$aUNRESTRICTED